您的位置: 首页 > 农业专利 > 详情页

COMPOSÉ D'ACIDE CARBOXYLIQUE À SUBSTITUTION QUINOLINYLE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, COMPOSITION PHARMACEUTIQUE ET UTILISATION ASSOCIÉES
专利权人:
Ltd.;Beijing Konruns Pharmaceutical Co.
发明人:
申请号:
EP17862141.3
公开号:
EP3530654A1
申请日:
2017.09.29
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present application provides a quinolyl-substituted carboxylic acid compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, as well as a method for preparing the compound, a use of the compound, and a formulation containing the quinolyl-substituted carboxylic acid compound or the pharmaceutically acceptable salt thereof. This type of compounds are inhibitors for AXL and/or VEGFR2 protein kinase, and can be used to treat diseases caused by abnormality of the two protein kinases, such as, tumor, etc.;
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充